Abbott Laboratories (ABT) Stock Analysis

Abbott Laboratories (ABT) Stock Analysis — AI Research | MarketCI

ABT

Market Closed

Abbott Laboratories

NYSEHealthcare Medical - Devices

114.00K employees

CEO: Robert Ford

Founded: 1980

$88.38

+$0.00(+NaN%)

Market Cap

153.94B

Beta

0.62

52W Range

N/A

Dividend Yield

2.76%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

ABT Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for ABT built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Buy

Pass %

71.43%

Score

5/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$147.16

AI Price Target

Machine learning • Price prediction

$71.25

Market Sentiment

News & social media analysis

0.12

Value Investor Price

Classic value analysis

$20.33

Financial Health

Bankruptcy risk assessment

5.29

Quality Score

Financial strength rating

6.00

AI Investment Grade

Deep analysis of filings & news

75.00

Key Investment Highlights

Important factors affecting ABT investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

58.14% Good

Conditions Met

25.00/43.00

Due Diligence Score

58.14%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Fail
	Fail
	Fail
	Fail
	Fail

Showing 1 to 6 of 46 conditions